Clustering data with hclust algorithm for (Study ST003367)
HILIC NEGATIVE ION MODE (Analysis AN005518)| Metabolite | Structure | F1 | F2 | F3 | F4 | F5 | F6 | F7 | F8 | F9 | F10 | F11 | F12 | F13 | F14 | F15 | F16 | F17 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| aCD 161 | ME881906 | NA | 0.43 | 0.44 | 0.44 | 0.89 | 0.91 | 0.88 | 0.77 | 0.35 | 0.39 | 0.44 | 0.93 | 8.01 | 0.90 | 0.76 | 0.80 | 1.61 |
| Acetyl-CoA 79 | ME881891 | 2.47 | 2.41 | 2.21 | 2.70 | 2.60 | 2.56 | 2.37 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Acetic PAR | ME881835 | 2.38 | 1.66 | 2.00 | 1.88 | 1.84 | 1.68 | 1.69 | 0.22 | 0.34 | 0.32 | 0.24 | 0.26 | 0.31 | 0.26 | 0.19 | 0.33 | 0.85 |
| Alanine NEG PAR | ME881838 | 2.37 | 2.44 | 2.23 | 2.37 | 2.27 | 2.30 | 2.11 | 0.14 | 0.16 | 0.18 | 0.17 | 0.16 | 0.17 | 0.16 | 0.04 | 0.04 | 0.13 |
| Acetyl-CoA 408 | ME881892 | 2.41 | 2.35 | 2.10 | 2.57 | 2.43 | 2.48 | 2.31 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Acetyl-CoA 461 | ME881893 | 2.30 | 2.24 | 2.04 | 2.45 | 2.29 | 2.22 | 2.10 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Factors:
| F1 | Sample source:BT-474 Breast cancer cells | Sample Type:Intracellular | Drug Treatment:100 uM C75 |
| F2 | Sample source:BT-474 Breast cancer cells | Sample Type:Intracellular | Drug Treatment:15 uM C75 |
| F3 | Sample source:BT-474 Breast cancer cells | Sample Type:Intracellular | Drug Treatment:1 uM C75 |
| F4 | Sample source:BT-474 Breast cancer cells | Sample Type:Intracellular | Drug Treatment:20 uM C75 |
| F5 | Sample source:BT-474 Breast cancer cells | Sample Type:Intracellular | Drug Treatment:40 uM C75 |
| F6 | Sample source:BT-474 Breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 uM C75 |
| F7 | Sample source:BT-474 Breast cancer cells | Sample Type:Intracellular | Drug Treatment:Control |
| F8 | Sample source:BT-474 Breast cancer cells | Sample Type:Medium | Drug Treatment:100 uM C75 |
| F9 | Sample source:BT-474 Breast cancer cells | Sample Type:Medium | Drug Treatment:15 uM C75 |
| F10 | Sample source:BT-474 Breast cancer cells | Sample Type:Medium | Drug Treatment:1 uM C75 |
| F11 | Sample source:BT-474 Breast cancer cells | Sample Type:Medium | Drug Treatment:20 uM C75 |
| F12 | Sample source:BT-474 Breast cancer cells | Sample Type:Medium | Drug Treatment:40 uM C75 |
| F13 | Sample source:BT-474 Breast cancer cells | Sample Type:Medium | Drug Treatment:5 uM C75 |
| F14 | Sample source:BT-474 Breast cancer cells | Sample Type:Medium | Drug Treatment:Control |
| F15 | Sample source:NA | Sample Type:Medium | Drug Treatment:Control |
| F16 | Sample source:NA | Sample Type:Medium | Drug Treatment:NA |
| F17 | Sample source:NA | Sample Type:QC | Drug Treatment:NA |
